Copper diethyldithiocarbamate as an activator of Nrf2 in cultured vascular endothelial cells by Fujie Tomoya et al.
Copper diethyldithiocarbamate as an activator
of Nrf2 in cultured vascular endothelial cells
著者 Fujie Tomoya, Murakami Masaki, Yoshida Eiko,
Tachinami Tadashi, Shinkai Yasuhiro, Fujiwara
Yasuyuki, Yamamoto Chika, Kumagai Yoshito,
Naka Hiroshi, Kaji Toshiyuki
journal or
publication title
Journal of biological inorganic chemistry :
JBIC
volume 21
number 2
page range 263-273
year 2016-04
権利 (C) The Author(s) 2016. This article is
published with open access at Springerlink.com
This article is distributed under the terms of
the Creative Commons Attribution 4.0
International License
(http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution,
and reproduction in any medium, provided you
give appropriate credit to the original
author(s) and the source, provide a link to
the Creative Commons license, and indicate if
changes were made.
URL http://hdl.handle.net/2241/00141797
doi: 10.1007/s00775-016-1337-z
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
1 3
J Biol Inorg Chem (2016) 21:263–273
DOI 10.1007/s00775-016-1337-z
ORIGINAL PAPER
Copper diethyldithiocarbamate as an activator of Nrf2 
in cultured vascular endothelial cells
Tomoya Fujie1 · Masaki Murakami1 · Eiko Yoshida1 · Tadashi Tachinami2 · 
Yasuhiro Shinkai3 · Yasuyuki Fujiwara4 · Chika Yamamoto5 · Yoshito Kumagai3 · 
Hiroshi Naka2 · Toshiyuki Kaji1 
Received: 28 October 2015 / Accepted: 8 January 2016 / Published online: 29 January 2016 
© The Author(s) 2016. This article is published with open access at Springerlink.com
dithiocarbamate activated Nrf2, copper ion, diethyldithi-
ocarbamate ligand with or without zinc or iron failed to 
exhibit this activity. Intracellular accumulation of Cu10 
was higher than that of Cu(II) and Cu(I). While the accu-
mulation of copper(II) bis(dimethyldithiocarbamate) was 
reduced by small interfering RNA (siRNA)-mediated 
knockdown of the copper transporter CTR1, the knock-
down did not affect Cu10 accumulation, indicating that 
Cu10 rapidly enters vascular endothelial cells via CTR1-
independent mechanisms. In addition, copper and iron 
complexes with other ligands tested could not activate Nrf2, 
suggesting that the intramolecular interaction between cop-
per and dithiocarbamate ligand is important for the activa-
tion of the transcription factor. Cu10 induced the expression 
of heme oxygenase-1, NAD(P)H quinone oxidoreductase 
1, and γ-glutamylcysteine synthetase, downstream proteins 
of Nrf2. It was suggested that Cu10-induced activation of 
Nrf2 was due to proteasome inhibition as well as binding 
to Kelch-like ECH-associated protein 1. Since the effects of 
Cu10 on vascular endothelial cells are unique and diverse, 
the copper complex may be a good molecular probe to ana-
lyze the functions of the cells.
Keywords Copper(II) bis(diethyldithiocarbamate) ·  
Bio-organometallics · Nrf2 · Proteasome · Keap1 · 
Endothelial cell
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ARE  Antioxidant response element
BPM  Biotin-PEAC5-maleimide
Cu01  Bis(hexafluoroactylacetonato)copper(II)
Cu02  N,N′-Bis(2-methoxycarbonyl-3-oxobutylidene)
ethylenediaminatocopper(II)
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Abstract The interest in organic–inorganic hybrid 
molecules as molecular probes for biological sys-
tems has been growing rapidly. Such hybrid molecules 
exhibit unique biological activities. Herein, copper(II) 
bis(diethyldithiocarbamate) (Cu10) was found to activate 
the transcription factor NF-E2-related factor 2 (Nrf2), 
which is responsible for regulating antioxidant and phase 
II xenobiotic enzymes, in vascular endothelial cells. The 
copper complex rapidly accumulated within cells and 
induced nuclear translocation of Nrf2, leading to upregula-
tion of the expression of downstream proteins without cyto-
toxic effects. However, while copper bis(2-hydroxyethyl)
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Cu07  Bis(1,3-propanediamine)copper(II) dichloride
Cu09  Copper(II) bis(2-hydroxyethyl)dithiocarbamate
Cu10  Copper(II) bis(diethyldithiocarbamate)
Cu15  N,N′-Bis(3,5-di-tert-butyl-2-oxidobenzyl)
ethylenediaminatocopper(II)
Cu17  Copper(II) bis(dimethyldithiocarbamate)
Cu18  Copper(II) bis(dibutyldithiocarbamate)
Cu19  Copper(II) bis(dibenzyldithiocarbamate)
Fe01  Tris(acetylacetonato)iron(III)
Fe02  Iron(II) diacetate
Fe03  Iron(II) phthalocyanine
Fe04  Sodium iron(III) ethylenediaminetetraacetate
Fe05  Iron(III) tris(diethyldithiocarbamate)
Keap1  Kelch-like ECH-associated protein 1
MG132  Z-Leu-Leu-Leu-CHO
Na01  Sodium diethyldithiocarbamate trihydrate
Ni06  Nickel(II) bis(diethyldithiocarbamate)
Nrf2  NF-E2-related factor 2
Zn01  Zinc(II) bis(diethyldithiocarbamate)
Introduction
NF-E2-related factor 2 (Nrf2) is a transcription factor that 
belongs to Cap‘n’Collar transcription factor family and 
has a basic leucine zipper domain [1]. Under basal condi-
tions, Nrf2 is bound to Kelch-like ECH-associated protein 
1 (Keap1), which is an adapter protein to Cullin3-based E3 
ubiquitin ligase, to prevent the proteasomal degradation of 
Nrf2 in the cytoplasm [2]. Keap1 also functions as a sensor 
protein against electrophiles and reactive oxygen species. 
Modification of the reactive thiols of Keap1 by electro-
philes results in the dissociation of Nrf2 from Keap1 and 
its nuclear translocation, allowing it to bind antioxidant 
response element (ARE) of the genes, thereby forming a 
heterodimerized complex of Nrf2 with co-activators such 
as small Maf [3].
Nrf2 mainly regulates the gene expression of antioxi-
dant and phase II xenobiotic metabolizing enzymes such as 
heme oxygenase-1, NAD(P)H quinone oxidoreductase 1, 
and γ-glutamylcysteine synthetase, by binding to the ARE 
of the promoter region of the genes. Induction of heme oxy-
genase-1 protects cells from oxidative injury by catalyzing 
heme to biliverdin, carbon monoxide, and iron [4]. NAD(P)
H quinone oxidoreductase 1 catalyzes the detoxification of 
quinones and their derivatives [5]. γ-Glutamylcysteine syn-
thetase is a rate-limiting enzyme in glutathione synthesis 
and consists of two subunits: the modifier subunit and the 
catalytic subunit. We postulate that low-molecular-weight 
molecular probes that activate Nrf2 and regulate cellular 
functions will be useful in analyzing the involvement of the 
transcription factor in the regulation of vascular endothelial 
cell functions.
Organic–inorganic hybrid molecules—organometallic 
compounds and metal coordination compounds—consist 
of metals and organic ligands in a common feature. These 
compounds can exhibit unique biological activities, differ-
ent from those of organic and inorganic compounds; their 
activities are attributable to their unique three-dimensional 
structures and electronic states [6–8]. It is most likely that 
organic–inorganic hybrid molecules exhibit their activi-
ties by modifying the activities of ligand, those of metal, 
or interaction between ligand and metal. We found that 
bis(l-cysteinato)zincate(II) serves as a specific zinc donor 
to the metal response element-binding transcription fac-
tor-1, a transcription factor containing six C2H2 zinc fin-
ger domains [6]. We have reported that an organobismuth 
compound—tris[2-(N,N-dimethylaminomethyl)phenyl]bis-
muthane—exhibits vascular endothelial cell-specific tox-
icity [7] and the cytotoxicity disappears when the bismuth 
atom is replaced with an antimony atom [8]. Recently, 
it was found that an organoantimony compound—
tris(pentafluorophenyl)stibane—causes transcriptional 
induction of metallothionein (submitted).
There are many reports on low-molecular-weight com-
pounds including toxic metal(loid)s that activate Nrf2; for 
example, sulforaphane, curcumin, tert-butylhydroquinone, 
1,2-naphthoquinone, methylmercury, and arsenite [9–13]. 
However, little is known about organic–inorganic hybrid 
molecules. In the present study, to obtain a good molecu-
lar probe for analysis of vascular endothelial cell functions 
that are regulated by Nrf2, we searched for organic–inor-
ganic hybrid molecules that activate Nrf2 without cytotox-
icity in cultured vascular endothelial cells. We found that 
copper(II) bis(diethyldithiocarbamate) (Cu10) exerts such 
a biological activity via proteasome inhibition as well as 
Keap1 modification in the cells.
Materials and methods
Materials
Bovine aortic endothelial cells were purchased from Cell 
Applications (San Diego, CA, USA). The following materi-
als were purchased from the respective vendors: Dulbecco’s 
modified Eagle’s medium and calcium- and magnesium-
free phosphate buffered saline from Nissui Pharmaceutical 
(Tokyo, Japan); fetal bovine serum from HyClone Labo-
ratories (Waltham, MA, USA); biotin-PEAC5-maleimide 
(BPM) from Dojindo (Kumamoto, Japan); rabbit poly-
clonal anti-actin antibody (A5060) and copper(II) diacetate 
(Cu04) from Sigma Aldrich Chemical (St. Louis, MO, 
USA); horseradish peroxidase-conjugated anti-rabbit IgG 
antibody (#7074) and anti-biotin, horseradish peroxidase-
linked antibody (#7075) from Cell Signaling (Beverly, 
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MA, USA); anti-NAD(P)H quinone oxidoreductase 1 anti-
body (ab2346) and donkey polyclonal antibody to goat 
IgG-horseradish peroxidase (ab6885) from Abcam (Tokyo, 
Japan); rabbit polyclonal anti Nrf2 antibody (H-300), rabbit 
polyclonal anti CTR1 antibody (FL-190), mouse polyclonal 
anti Keap1 antibody (H-190), and rabbit polyclonal anti 
γ-glutamylcysteine synthetase modifier subunit antibody 
(FL-274) from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA); rabbit polyclonal anti-heme oxygenase-1 antibody 
(ADI-SPA-895) and ubiquitin monoclonal antibody (ADI-
SPA-203), and MG-132 from Enzo Life Sciences (Farming-
dale, NY, USA); nitric oxide, hydrogen peroxide, copper(II) 
bis(dimethyldithiocarbamate) (Cu17), and sodium die-
thyldithiocarbamate trihydrate (Na01) from Wako Pure 
Chemical Industries (Osaka, Japan); 3,5-diaminobenzoic 
acid, bis(hexafluoroactylacetonato)copper(II) (Cu01), 
bis(1,3-propanediamine)copper(II) dichloride (Cu07), 
copper(II) bis(2-hydroxyethyl)dithiocarbamate (Cu09), 
copper(II) bis(diethyldithiocarbamate) (Cu10), iron(II) 
phthalocyanine (Fe03), sodium iron(III) ethylenediamine-
tetraacetate (Fe04), iron(III) tris(diethyldithiocarbamate) 
(Fe05), nickel(II) bis(diethyldithiocarbamate) (Ni06), 
zinc(II) bis(diethyldithiocarbamate) (Zn01), zinc(II) 
bis(dibutyldithiocarbamate), and zinc(II) bis(dibenzyldi-
thiocarbamate) from Tokyo Chemical Industry (Tokyo, 
Japan); iron(II) diacetate (Fe02) from Acros Organics 
(Thermo Fisher Scientific, Geel, Belgium); Chemi-Lumi 
One L and other reagents were from Nacalai Tesque 
(Kyoto, Japan).
Synthesis
N,N ′ -B i s (2 -methoxycarbony l -3 -oxobu ty l idene)
ethylenediaminatocopper(II) (Cu02), bis(salicylidene)
ethylenediaminatocopper(II) (Cu03), and N,N′-Bis(3,5-
di-tert-butyl-2-oxidobenzyl)ethylenediaminatocopper(II) 
(Cu15) were synthesized by employing literature proce-
dures [14–16]. Copper(II) bis(dibutyldithiocarbamate) 
(Cu18) was synthesized by mixing copper(II) diacetate 
(3.63 g, 20 mmol) and zinc(II) bis(dibutyldithiocarbamate) 
(9.48 g, 20 mmol) in a 1:1 molar ratio in a biphasic mix-
ture of dichloromethane (1 L), water (100 mL), and 25 % 
aqueous ammonia (200 mL) at room temperature for 1 h 
under aerobic conditions. The organic layer was sepa-
rated, washed with water, concentrated under reduced 
pressure, and dried in vacuum to yield the desired prod-
uct as a black solid (9.32 g, 99 %). Elemental analysis 
calculated for [C18H36CuN2S4]: C, 45.78; H, 7.68; N, 
5.93 and found: C, 46.04; H, 7.80; N, 5.65. Copper(II) 
bis(dibenzyldithiocarbamate) (Cu19) was prepared analo-
gously using zinc(II) bis(dibenzyldithiocarbamate) (92 % 
yield). Elemental analysis calculated for [C30H28CuN2S4]: 
C, 59.23; H, 4.64; N, 4.60 and found: C, 59.64; H, 4.68; 
N, 4.24. The elemental analyses were recorded on a Yanaco 
CHN recorder MT-6 at the Chemical Instrumental Center, 
Research Center for Materials Science, Nagoya University.
Western blot analysis
Confluent cultures of vascular endothelial cells in 35-mm 
culture dishes were incubated at 37 °C for 1, 2, 3, 4, 6, 8, 
12, or 24 h with Cu10 or other compounds at 0.1, 0.5, 1, 2, 
5, or 10 µM. The cells were washed twice with ice-cold cal-
cium- and magnesium-free phosphate buffered saline; total 
cellular proteins obtained by lysis in sodium dodecyl sul-
fate sample buffer (50 mM Tris–HCl buffer solution con-
taining 2 % sodium dodecyl sulfate and 10 % glycerol, pH 
6.8) were incubated at 95 °C for 5 min. The protein con-
centration was determined using a bicinchoninic acid pro-
tein assay reagent kit (Thermo Fisher Scientific, Waltham, 
MA, USA). 2-Mercaptoethanol and bromophenol blue 
(1.67 % each) were added to the proteins (10 μg). The pro-
teins were separated by SDS–polyacrylamide gel electro-
phoresis on 10 % polyacrylamide gel and transferred onto 
a polyvinylidene difluoride membrane at 2 mA/cm2 for 1 h. 
The membrane was blocked with 5 % skim milk in 20 mM 
Tris–HCl buffer containing 150 mM NaCl and 0.1 % 
Tween-20, pH 7.5 and incubated with primary antibodies 
(1:200) at 4 °C overnight. The membrane was washed with 
20 mM Tris–HCl buffer solution containing 150 mM NaCl 
and 0.1 % Tween 20 (pH 7.5), and then incubated with 
horseradish peroxidase-conjugated secondary antibodies 
for 1 h at room temperature. Immunoreactive bands were 
visualized by enhanced chemiluminescence and scanned 
by LAS3000 (Fujifilm, Tokyo, Japan). Separately, vascular 
endothelial cells were treated with Cu10 at 0.1, 0.5, 1, 5, or 
10 µM for 3 or 6 h and the nuclear fraction was prepared 
from the cell layer using the NE-PER Nuclear Cytoplas-
mic Extraction Reagents (Thermofisher Scientific). Nuclear 
protein concentration was determined by a bicinchoninic 
acid protein assay reagent kit (Thermo Fisher Scientific). 
The samples (8 µg protein) were mixed with 50 mM Tris–
HCl solution containing 8 % glycerol, 2 % sodium dode-
cyl sulfate, 2-mercaptoethanol, and 0.005 % bromophenol 
blue, pH 6.8 and incubated at 95 °C for 3 min. These sam-
ples were analyzed by western blotting as described above.
Intracellular accumulation of metals
Confluent cultures of vascular endothelial cells were 
incubated in 6-well plates at 37 °C for 3 h in serum-free 
Dulbecco’s modified Eagle’s medium in the presence of 
CuSO4, sodium diethyldithiocarbamate trihydrate (Na01), 
zinc(II) bis(diethyldithiocarbamate) (Zn01), iron(III) 
tris(diethyldithiocarbamate) (Fe05), copper(II) bis(2-
hydroxyethyl)dithiocarbamate (Cu09), CuSO4 [Cu(II)], 
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CuSO4 with 1 mM ascorbate [Cu(I)] [17], or Cu10 (10 µM 
each). In another experiment, subconfluent cultures of 
bovine aortic endothelial cells were transfected with con-
trol or CTR1 small interfering RNA (siRNA) as described 
below and incubated at 37 °C for 3 h in the presence of 
Cu10, Cu17, Cu18, and Cu19 (10 µM each). After incuba-
tion, the medium was discarded and the cells were washed 
twice with ice-cold calcium- and magnesium-free phos-
phate buffered saline. The cell lysates were prepared by 
addition of 100 µL 50 mM Tris–HCl containing 2 % SDS 
and 10 % glycerol (pH 6.8). The cell lysate was incubated 
at 95 °C for 3 min and a portion was treated with nitric 
acid-H2O2 at 130 °C for 1 day to degrade proteins and dis-
solved with 2 mL of 0.1 M nitric acid; the diluted sam-
ples were used for determination of zinc, copper, and iron 
content by inductively coupled plasma mass spectrometry 
(ERAN DRC II, PerkinElmer, MA, USA). Another portion 
of the cell lysate was analyzed for DNA content by fluoro-
metric method [18] to normalize the content of the metals 
per µg DNA.
Transfection
Vascular endothelial cells were cultured and siRNAs 
(Bioneer, Daejeon, Korea) for the copper transporter CTR1 
were transfected using RNAiMAX reagent (Invitrogen, 
Crlsbad, CA, USA), as described previously [19]. Briefly, 
the cells were cultured in Dulbecco’s modified Eagle’s 
medium supplemented with 10 % fetal bovine serum 
in 35-mm dishes until 70–80 % confluence. Separately, 
siRNA duplex (35 pmol/mL) and transfection reagent (2 
μL/mL) were mixed with Opti-MEM (Thermofisher Scien-
tific) and incubated for 20 min at room temperature. The 
mixture was added to the culture medium, and the cells 
were incubated at 37 °C for 24 h and then treated with or 
without Cu10, Cu17, Cu18, or Cu19 (10 µM each) for 3 h. 
The sequences of the sense and antisense strands of siRNA 
were as follows: bovine CTR1 siRNA, 5-AUAAGGAUG-
GUUCCAUUUGdTdT-3 (sense) and 5-CAAAUGGAAC-
CAUCCUUAU-3 (antisense). A nonspecific sequence was 
used as the siRNA negative control (Qiagen, Valencia, CA, 
USA).
Keap1 and biotin‑PEAC5‑maleimide‑labeling assay 
in vitro
The mouse recombinant Keap1 construct was prepared 
as described previously [10, 20]. The recombinant Keap1 
protein was expressed as a C-terminal His-tagged fusion 
protein in BL21(DE3)pLysS E. coli cells and puri-
fied using a ProBond nickel-resin. The BPM-labeling 
assay was performed according to the method described 
by Toyama et al. [20]. Briefly, mouse recombinant 
Keap1 protein (2 µg) was incubated with Cu10 (1, 10, 
or 100 µM) at 37 °C for 30 min in 100 mM Tris–HCl 
buffer solution (pH 7.5). After incubation, 25 µM bio-
tin-PEAC5-maleimide was added to the samples and the 
samples were incubated at 37 °C for 30 min. The samples 
were electrophoresed on 10 % sodium dodecyl sulfate–
polyacrylamide gel in 50 mM Tris–HCl containing 2 % 
SDS, 8 % glycerol, and 0.005 % bromophenol blue (pH 
6.8) without 2-mercaptoethanol and were incubated at 
37 °C for 30 min. They were then subjected to immunob-
lotting as described above.
Statistical analysis
The data were analyzed for statistical significance by Stu-
dent’s t test when possible. P values less than 0.01 were 
considered statistically significant.
Results
Cu10 activates Nrf2 in vascular endothelial cells
Figure 1 shows the activation of Nrf2 by Cu10 (the struc-
ture is shown in Fig. 1a) in vascular endothelial cells. 
Cu10 at 10 µM or less increased the expression of Nrf2 
in a concentration-dependent manner (Fig. 1b). Cu10 at 
10 µM increased the expression of Nrf2 after 2 h or longer 
in a time-dependent manner; the highest expression was 
observed at 8 h and gradually reduced thereafter (Fig. 1c). 
Nrf2 was detected in the nuclear fraction after 3 and 6 h in 
vascular endothelial cells treated with Cu10 at 5 and 10 µM 
(Fig. 1d). After a 24 h treatment with Cu10 at 0.1 µM or 
higher, the expression of downstream proteins of Nrf2—
heme oxygenase-1, NAD(P)H quinone oxidoreductase 1, 
and γ-glutamylcysteine synthetase modifier subunit—sig-
nificantly increased in a concentration-dependent manner 
(Fig. 1e).
Role of copper in the Cu10 molecule in Nrf2 activation
In order to examine whether copper in the Cu10 molecule 
is critical to the activation of endothelial Nrf2, the effects 
of zinc and iron complexes with the same ligand of Cu10 
on Nrf2 activation were investigated. In this experiment, 
copper sulfate, Na01 as the ligand of Cu10, and Cu09 were 
investigated. The structures of the tested metal complexes 
and Na01 are shown in Fig. 2a. As shown in Fig. 2b, Cu10 
and Cu09 increased the expression of Nrf2; however, cop-
per sulfate, Na01, Zn01, and Fe05 failed to exhibit such an 
activity (Fig. 2b), indicating that copper is required for die-
thyldithiocarbamate complexes to activate Nrf2 in vascular 
endothelial cells. Copper sulfate, Zn01, and Fe05 did not 
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accumulate within the cells after a 3 h treatment, whereas 
significant accumulation of Cu10 and Cu09 was observed 
(Fig. 2c), suggesting that Nrf2-activating activity of the 
copper complexes may depend on their high intracellular 
accumulation.
Since Cu10 and Cu09 highly accumulated within vas-
cular endothelial cells and enhanced Nrf2 expression, 
Cu(II) may have been reduced to Cu(I) by thiol groups 
in the thiocarbamate ligands and Cu(I) ion released from 
the Cu10 molecule efficiently entered the cells through 
the copper transporter CTR1 that mediated Cu(I) uptake 
[17]. To examine this hypothesis, we compared the intra-
cellular accumulation of Cu(II), Cu(I), and Cu10 in vas-
cular endothelial cells and determined the involvement 
of CTR1 in the uptake of copper complexes with thiol 
groups. The structures of the tested copper complexes are 
shown in Fig. 3a. The intracellular accumulation of Cu10 
was high in vascular endothelial cells compared with 
Cu(II) and Cu(I) (Fig. 3b). The accumulation of copper(II) 
bis(dimethyldithiocarbamate) (Cu17) was significantly 
reduced by siRNA-mediated knockdown of CTR1; how-
ever, Cu10, copper(II) bis(dibutyldithiocarbamate) 
(Cu18), and copper(II) bis(dibenzyldithiocarbamate) 
(Cu19) accumulation was not affected by the knockdown 
(Fig. 3c, d). Cu17 as well as Cu10 activated Nrf2, regard-
less of whether CTR1 was knocked down or not (Fig. 3e). 
However, Cu18 and Cu19 highly accumulated in the cells 
(Fig. 3d), regardless of CTR1 expression, but failed to acti-
vate Nrf2 in vascular endothelial cells.
Role of the ligand in the Cu10 molecule in Nrf2 
activation
It is possible that copper complexes in general activate 
endothelial Nrf2. To examine this possibility, we evalu-
ated copper complexes with various ligands. In this experi-
ment, compounds containing iron were also examined. The 
compounds used in this experiment are shown in Fig. 4a. 
Among the tested copper complexes, only Cu10 and Cu09 
increased the expression of Nrf2 (Fig. 4b), suggesting that 
the ligand as well as the copper ion is important for the 
activation of Nrf2 by Cu10. Other compounds could not 
activate the transcription factor. The expression of Nrf2 in 
vascular endothelial cells treated with Cu01, Cu02, Cu03, 
Cu04, Cu07, Cu09, Cu15, Fe01, Fe02, Fe03, Fe04, Fe05, 
CuSO4, and Na01 is shown in S1.
(a)
(b)
(d) (e)
(c)
Fig. 1  Activation of Nrf2 by Cu10 in vascular endothelial cells. a 
The structure of Cu10. b The expression of Nrf2. Confluent cultures 
of bovine aortic endothelial cells were incubated at 37 °C for 3 h in 
the presence or absence of Cu10 (0.1, 0.5, 1, 5, or 10 µM). c Time 
course of the effect of Cu10 on the expression of Nrf2. Confluent cul-
tures of bovine aortic endothelial cells were incubated at 37 °C for 1, 
2, 3, 4, 6, 8, 12, and 24 h in the presence or absence of Cu10 (10 µM). 
d The expression of Nrf2 in the nuclei. Confluent cultures of bovine 
aortic endothelial cells were incubated at 37 °C for 3 and 6 h in the 
presence or absence of Cu10 (0.1, 0.5, 1, 5, or 10 µM). e The expres-
sion of downstream proteins of Nrf2. Confluent cultures of bovine 
aortic endothelial cells were incubated at 37 °C for 24 h in the pres-
ence or absence of Cu10 (0.1, 0.5, 1, 5, or 10 µM). HO-1 heme oxy-
genase-1, NQO1 (upper bands) NAD(P)H quinone oxidoreductase 1, 
GCLM γ-glutamylcysteine synthetase modifier subunit
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Characterization of Nrf2 activation by Cu10
The activation of Nrf2 by Cu10 was compared with that 
by sulforaphane (the structure is shown in Fig. 5a), an iso-
thiocyanate that modifies Keap1 and activates Nrf2 [21]. 
It was shown that the Nrf2-activating activity of Cu10 and 
sulforaphane is almost comparable (Fig. 5b); however, 
the expression of Nrf2 downstream proteins induced by 
Cu10 and sulforaphane differed. Specifically, Cu10 mark-
edly increased the expression of heme oxygenase-1 and 
γ-glutamylcysteine synthetase modifier subunit, whereas 
the expression of NAD(P)H quinone oxidoreductase 1 was 
markedly upregulated by sulforaphane (Fig. 5c), suggesting 
that the mechanisms underlying Nrf2 activation by Cu10 
may be different from that of sulforaphane.
Activation mechanisms of Nrf2 by Cu10
To examine whether Cu10 can bind Keap1, the BPM-labe-
ling assay was performed. Incubation of recombinant mouse 
Keap1 with Cu10 decreased the signal of biotinylated Keap1 
protein (Fig. 6), indicating that Cu10 was bound to Keap1. 
As shown in the previous study [20], cadmium bound to 
Keap1. Since Keap1 binds Nrf2 and protects it from pro-
teasomal degradation, inhibition of proteasome can be a 
mechanism through which Nrf2 is activated. To examine 
this possibility, the proteasome inhibitory activity of Cu10 
was investigated. In this experiment, Zn01 and nickel(II) 
bis(diethyldithiocarbamate) (Ni06) were also evaluated (the 
structures are shown in Fig. 7a). It was shown that Cu10 
increased the ubiquitinated proteins in a concentration- and 
time-dependent manner (Fig. 7b), indicating that the copper 
complex inhibits proteasome; MG132, a typical proteasome 
inhibitor also increased the level of ubiquitinated proteins. 
Zn01 and Ni06 failed to increase both Nrf2 expression and 
level of ubiquitinated proteins (Fig. 7c). Since cadmium, a 
toxic heavy metal in vascular endothelial cells [22], did not 
display proteasome inhibitory activity, it is suggested that 
the proteasome inhibition by Cu10 was not a nonspecific 
effect of the copper complex (Fig. 7d).
(a)
(b)
(c)
Fig. 2  Role of copper in the Cu10 molecule in Nrf2 activation in 
vascular endothelial cells. a The structures of Na01, Zn01, Fe05, 
Cu09, and Cu10. b The expression of Nrf2. Confluent cultures of 
bovine aortic endothelial cells were incubated at 37 °C for 3 h in the 
presence or absence of CuSO4, Na01, Zn01, Fe05, Cu09, and Cu10 
(10 µM each). c Intracellular accumulation of CuSO4, Na01, Zn01, 
Fe05, Cu09, and Cu10. Confluent cultures of bovine aortic endothe-
lial cells were incubated at 37 °C for 3 h in the presence or absence 
of CuSO4, Na01, Zn01, Fe05, Cu09, and Cu10 (10 µM each). White, 
gray, and black bars indicate the content of zinc, iron, and copper, 
respectively. Values are mean ± SE of three samples. *Significantly 
different from the control, P < 0.01
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Discussion
Dithiocarbamates are metal-chelating compounds that 
affect the activities of various metal-binding proteins such 
as nuclear factor-kappa B and superoxide dismutase-1 
[23, 24]. The present study revealed the previously unrec-
ognized biological activities of metal diethyldithiocarba-
mate coordination compounds. The following results were 
obtained: (1) copper(II) bis(diethyldithiocarbamate), Cu10, 
activates Nrf2 in vascular endothelial cells without cytotox-
icity, (2) the combination of copper with the diethyldithi-
ocarbamate ligand is essential for the effect of Cu10, (3) 
Cu10 rapidly enters the cells and induces nuclear translo-
cation of Nrf2, resulting in the induction of downstream 
proteins such as heme oxygenase-1, NAD(P)H quinone 
oxidoreductase 1, and γ-glutamylcysteine synthetase modi-
fier subunit, (4) high concentrations of Cu10 accumulated 
within the cells compared with Cu(II) and Cu(I), regardless 
of CTR1 expression, and Nrf2 activation of copper com-
plexes with thiol groups depended on the structures and 
not on intracellular accumulation; (5) both proteasome 
inhibition and binding to Keap1 are mechanisms through 
which Cu10 activates Nrf2. In general, the relationship 
between the biological activity and the structure of a cer-
tain organic–inorganic hybrid molecule could follow any 
of the following three patterns. First, the ligand has bio-
logical activity and intramolecular metal intensifies the 
activity. Second, the metal has biological activity and the 
ligand intensifies the activity. Third, the biological activ-
ity of either the ligand or the metal is only slight but the 
hybrid molecule exhibits activity owing to their discrete 
molecular structures that originate from metal–ligand 
coordination (i.e., intramolecular interaction). Since nei-
ther copper sulfate nor Na01 could activate Nrf2, we pos-
tulate that the activation of Nrf2 by Cu10 is induced by 
the intramolecular interaction between copper atom and 
Fig. 3  Intracellular accumulation of Cu(II), Cu(I), and Cu10 in vas-
cular endothelial cells, and involvement of CTR1 in the accumula-
tion of copper complexes. a The structures of Cu10, Cu17, Cu18, 
and Cu19. b Intracellular accumulation of Cu(II), Cu(I), and Cu10. 
Confluent cultures of bovine aortic endothelial cells were incu-
bated at 37 °C for 3 h in the presence or absence of CuSO4 [Cu(II)], 
CuSO4 with 1 mM ascorbate [Cu(I)], and Cu10 (10 µM each). Values 
are expressed as mean ± SE for the four samples. c CTR1 protein 
expression after siRNA-mediated knockdown of CTR1. Subconflu-
ent cultures of bovine aortic endothelial cells were transfected with 
control or CTR1 siRNA and incubated at 37 °C in the presence or 
absence of Cu10, Cu17, Cu18, and Cu19 (10 µM each) for 3 h. d 
Intracellular accumulation of Cu10, Cu17, Cu18, and Cu19. Subcon-
fluent cultures of bovine aortic endothelial cells were transfected with 
control or CTR1 siRNA and incubated at 37 °C in the presence or 
absence of Cu10, Cu17, Cu18, and Cu19 (10 µM each). Values are 
expressed as mean ± SE for the four samples. *Significantly differ-
ent from the control, P < 0.01. e Nrf2 expression. Subconfluent cul-
tures of bovine aortic endothelial cells were transfected with control 
or CTR1 siRNA and incubated at 37 °C in the presence or absence of 
Cu10, Cu17, Cu18, and Cu19 (10 µM each)
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Fig. 4  Role of the ligand in Cu10 molecule in Nrf2 activation in vas-
cular endothelial cells. a The structures of Cu01, Cu02, Cu03, Cu04, 
Cu07, Cu09, Cu10, Cu15, Fe01, Fe02, Fe03, and Fe04. b The expres-
sion of Nrf2. Confluent cultures of bovine aortic endothelial cells 
were incubated at 37 °C for 3 h in the presence or absence of Cu01, 
Cu02, Cu03, Cu04, Cu07, Cu09, Cu10, Cu15, Fe01, Fe02, Fe03, and 
Fe04 (10 µM each)
(a)
(b) (c)
Fig. 5  Characterization of Nrf2 activation by Cu10 compared with 
sulforaphane. a The structures of Cu10 and sulforaphane. b The 
expression of Nrf2. Confluent cultures of bovine aortic endothelial 
cells were incubated at 37 °C for 3 h in the presence or absence of 
Cu10 (5 or 10 µM) or sulforaphane (1, 5, or 10 µM). c The expression 
of downstream proteins of Nrf2. Confluent cultures of bovine aortic 
endothelial cells were incubated at 37 °C for 24 h in the presence or 
absence of Cu10 (5 or 10 µM) or sulforaphane (1, 5, or 10 µM). HO-
1 heme oxygenase-1, NQO1 NAD(P)H quinone oxidoreductase 1, 
GCLM γ-glutamylcysteine synthetase modifier subunit
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the diethyldithiocarbamate ligand. It is also suggested that 
this interaction is required for rapid accumulation of Cu10 
within vascular endothelial cells.
The mechanisms of high intracellular accumulation of 
Cu10 are critical for understanding the mechanisms by 
which Cu10 activates Nrf2 in vascular endothelial cells. 
Copper complexes with thiol groups, such as Cu10 and 
Cu09, markedly accumulate within the cells and activate 
Nrf2, whereas copper complexes without thiol groups 
failed to activate Nrf2, suggesting that Cu(II) may be 
reduced to Cu(I) by thiol groups in thiocarbamate ligands, 
and the Cu(I) ion released from the Cu10 molecule effi-
ciently entered the cells via the copper transporter CTR1 
[17]. In other words, Cu10 served as a donor of Cu(I) to 
CTR1, and consequently, the copper ion, but not the Cu10 
molecule, activated Nrf2 through modification of Keap1. 
However, intracellular accumulation of Cu10 was much 
higher than that of Cu(II) and Cu(I) and was not affected 
by siRNA-mediated knockdown of CTR1. In contrast, 
the accumulation of Cu17 was significantly reduced by 
the knockdown, suggesting that CTR1 is at least partly 
involved in the uptake of Cu17. Therefore, the possibility 
that CTR1 partly mediates the uptake of copper complexes 
as well as cisplatin [25], cannot be excluded, and it is sug-
gested that CTR1 expression is not the major mechanism 
of Cu10 uptake. In addition, Cu18 and Cu19 were also 
highly accumulated within the cells, but failed to activate 
Nrf2, thereby suggesting that activation of Nrf2 by cop-
per complexes depends on the ligand structure rather than 
the copper ion released from the molecule. Thus, although 
the details are yet to be elucidated, an assumption can be 
made that Cu10 was transported as a molecule, and modi-
fied Keap1 and activated Nrf2 in vascular endothelial cells.
Ubiquitin–proteasome system is responsible for the 
degradation of numerous proteins, including Nrf2. The 
26S proteasome consists of two complexes—the 20S 
Fig. 6  Binding of Cu10 to Keap1. Recombinant mouse Keap1 pro-
tein (2 µg) was incubated with Cu10 (1, 10, or 100 µM) at 37 °C for 
30 min in 100 mM Tris–HCl (pH 7.5) and then further incubated at 
37 °C for 30 min after addition of 25 µM biotin-PEAC5-maleimide. 
The samples were subjected to western blotting, which was per-
formed using anti-biotin antibody (BPM) and anti-Keap1 antibody 
(Keap1). Cadmium chloride (CdCl2) was used as the positive control
Fig. 7  Proteasome inhibition 
by Cu10, Zn01, Ni06, and 
CdCl2 in vascular endothelial 
cells. a The structures of Cu10, 
Zn01, and Ni06. b Proteasome 
inhibitory activity. Conflu-
ent cultures of bovine aortic 
endothelial cells were incubated 
at 37 °C for 8 h in the pres-
ence or absence of Cu10, Zn01, 
Ni06, or cadmium chloride 
(CdCl2) (1, 5, 10 µM each). 
MG132 was used as positive 
control. The total cell lysates 
were subjected to western 
blotting, which was performed 
using an anti-ubiquitin antibody
(a) (b)
(c) (d)
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proteolytic core and the 19S regulatory complex [26]. Pre-
viously, it was reported that Cu10 inhibits proteasomal 
function by inhibiting both 20S chymotrypsin-like activity 
and 19S complex in human breast cancer MBA-MD-231 
cells [27]. In this report, Zn01 but not Ni06 showed pro-
teasome inhibitory activity, suggesting that the type of 
metal complexes that have similar biological activities may 
depend on cell types. While the reason underlying this cell 
type dependency is unclear, it is certain that Cu10 exhib-
its proteasome inhibitory activity and inhibits the degra-
dation of Nrf2 in vascular endothelial cells. Proteasome 
inhibition would be one of the major mechanisms by which 
Cu10 activates endothelial Nrf2. Conversely, it was shown 
that Cu10 binds Keap1 and this led to the release of Nrf2 
from Keap1 followed by nuclear translocation of Nrf2. 
There are several reactive cysteine residues in the Keap1 
molecule and the residues that are involved in Nrf2 activa-
tion are Cys151 in the BTB domain and Cys273/Cys288 in 
the IVR domain [28, 29]. The modified cysteine residues 
that are employed for Nrf2 activation depend on the com-
pounds that activate Nrf2 [30, 31]. For example, zinc ion 
binds to both Cys273 and Cys288 and activates Nrf2 [32]. 
It is suggested that Cu10 binds to at least one of the three 
reactive cysteine residues of the Keap1 molecule. While it 
is unclear as to which cysteine residue(s) are modified by 
Cu10, it is postulated that modification of Keap1 is one of 
the major mechanisms by which Cu10 activates endothelial 
Nrf2. It was shown that, among the downstream proteins 
of Nrf2, heme oxygenase-1 and γ-glutamylcysteine syn-
thetase modifier subunit were markedly induced by Cu10, 
whereas sulforaphane, which is bound to Keap1 and acti-
vates Nrf2, strongly induced NAD(P)H quinone oxidore-
ductase 1. This difference in the induction of downstream 
protein between Cu10 and sulforaphane may be attributable 
to the difference of Nrf2 activation mechanisms. However, 
this is yet to be elucidated.
A compound that has a specific target biomolecule is an 
excellent tool to analyze the role of the biomolecule in the 
regulation of some biological systems. However, a com-
pound that has multiple targets is also useful to analyze the 
relationship among the targets. Cu10 appears to belong to 
the latter case. In fact, we have analyzed vascular endothe-
lial cell functions using Cu10. Metallothionein is a low-
molecular-weight, cysteine-rich, metal-containing, induc-
ible protein, which protects cells from heavy metals and 
oxidative stress [33]. Since cadmium and zinc induce metal-
lothionein, they have been used as tools to analyze mecha-
nisms underlying metallothionein induction. However, the 
metals cannot be good tools because vascular endothelial 
cells are sensitive to cadmium [34] and zinc does not induce 
metallothionein in the cells [35, 36]. Recently, we found 
that this copper complex induces metallothionein in vas-
cular endothelial cells; activation of Nrf2 and consequent 
activation of ARE in the promoter region of metallothionein 
genes contribute to the induction of specific metallothionein 
isoform [19]. Further studies on Cu10 as a tool to analyze 
vascular endothelial cell functions are ongoing.
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